News room

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Media contact


Nicklas Westerholm, CEO

Marie-Louise Alamaa, CFO

Calendar and upcoming reports

May 6, 2021
Erik Penser bank- Commercialization of pharmaceuticals

May 25, 2021
ABGSC Life Science Summit

Show more events



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10